Ceapro Announces Grant of Stock Options
EDMONTON, ALBERTA -- (Marketwire) -- 01/15/13 -- Ceapro Inc. (TSX
VENTURE:CZO) today announced the granting of stock options to its
employees, directors, and officers for a total of 1,400,000 stock
options, each with an exercise price of $0.10. Each grant vests in
three equal instalments, the first of which vests immediately with
the second and third instalments vesting on the first and second
anniversaries of the date of grant. Each option is exercisable, once
vested, for a period of ten years from the date of grant.
Of note, a total of 575,000 of the stock options were granted to
directors and officers. The granting of all options is subject to TSX
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary
business activities relate to the development and commercialization
of natural products for personal care and cosmetic industries using
proprietary technology and natural, renewable resources. The
commercial line of natural active ingredients include beta glucan,
avenanthamides (colloidal oat extract), oat powder, oat oil, oat
peptides, and lupin peptides.
To learn more about Ceapro, visit www.ceapro.com.
The TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Chief Financial Officer
(780) 917-8376 (Edmonton)
Press spacebar to pause and continue. Press esc to stop.